Fig. 2

Amyloid-β (Aβ) content in the cerebrospinal fluid (CSF) of APP_SWE/PS1_ΔE9 (APP/PS1) mice chronically treated with escitalopram. a Content of Aβ40 and Aβ42 and (b) the Aβ42/Aβ42 ratio in CSF of APP/PS1 mice treated with 5 mg/kg/day escitalopram from 3 to 9 months of age. Data are presented as mean ± SEM